Business Services Industry
Five new prescription drugs are nearing approval from the FDA.(HEALTH)
Kiplinger Letter, The, May, 2007
Five new prescription drugs are nearing approval from the FDA. All are potential blockbusters, helping drug firms replace profits lost because of expired patents on Zocor, Ambien and other popular drugs.
Awaiting the nod this year or next: A cervical cancer vaccine, Cervarix, from GlaxoSmithKline. An obesity-fighting drug, Acomplia, from Sanofi-Aventis. It blocks signals to the brain that can cause people to overeat. A treatment for major depressive disorders, Pristiq, from Wyeth Pharmaceuticals, which also wants the FDA to approve it to treat hot flashes from menopause. A clot blocker for stroke patients, Prasugrel, from Eli Lilly. And a once-daily remedy for type 2 diabetes, Galvus, from Novartis. It can be used alone or with other treatments.
Most Recent Business Articles
- Multiple criteria evaluation and optimization of transportation systems
- Multi-criteria analysis procedure for sustainable mobility evaluation in urban areas
- A two-leveled multi-objective symbiotic evolutionary algorithm for the hub and spoke location problem
- Multi-criteria analysis for evaluating the impacts of intelligent speed adaptation
- The development of Taiwan arterial traffic-adaptive signal control system and its field test: a Taiwan experience
Most Recent Business Publications
Most Popular Business Articles
- 7 tips for effective listening: productive listening does not occur naturally. It requires hard work and practice - Back To Basics - effective listening is a crucial skill for internal auditors
- FAS 109: a primer for non-accountants - Financial Accounting Standards Board's "Statement 109: Accounting for Income Taxes"
- LIFO vs. FIFO: a return to the basics
- Design a commission plan that drives sales - Sales Commissions
- Too Young to Rent a Car? - 25-years-old the minimum age for car renting - Brief Article
